tiprankstipranks
Trending News
More News >
Bain Capital Specialty Finance (BCSF)
NYSE:BCSF

Bain Capital Specialty Finance (BCSF) AI Stock Analysis

Compare
436 Followers

Top Page

BCSF

Bain Capital Specialty Finance

(NYSE:BCSF)

Select Model
Select Model
Select Model
Neutral 62 (OpenAI - 5.2)
Rating:62Neutral
Price Target:
$14.00
â–²(3.70% Upside)
Action:ReiteratedDate:01/30/26
BCSF scores as moderately attractive: solid underlying profitability and cash generation are the main support, with valuation boosted by a low P/E and very high yield. The score is held back by weak technicals (below key moving averages with negative MACD) and some near-term fundamental uncertainty (TTM revenue softness and balance-sheet data inconsistency), while earnings-call commentary and recent funding/dividend actions are net supportive but not enough to offset the technical weakness.
Positive Factors
Dividend coverage / net investment income
Consistent net investment income that exceeds the regular dividend demonstrates durable earnings coverage from the loan portfolio. This fundamental cash generation supports the company's ability to continue distributions, reduces reliance on capital transactions for payouts, and underpins long-term income credibility.
Credit quality / low non-accruals
Low and stable non-accrual percentages point to disciplined underwriting and stable portfolio credit performance. For a middle-market-focused BDC, sustained low defaults support predictable interest income, limit capital impairment risk and allow steady deployment of capital into new originations over multiple quarters.
Access to long-term funding
Issuing long-dated fixed-rate notes materially strengthens the firm’s funding profile and reduces near-term refinancing risk. Reliable market access and longer-duration liabilities support scaled origination, better asset-liability matching, and strategic growth of the lending book over the medium term.
Negative Factors
NAV volatility from idiosyncratic markdowns
A single-loan markdown materially impacted NAV, highlighting concentration and valuation risk in a fair-value driven portfolio. Persistent NAV swings can erode investor equity, complicate dividend coverage assessments, and raise the probability of future write-downs that harm long-term returns.
Declining portfolio yield and investment income
A structural decline in portfolio yield reduces net investment income and compresses spreads on new originations. Over several quarters this lowers recurring earnings and constrains the BDC’s ability to grow distributable cash flow, especially if competition or rate moves limit repricing power.
Balance-sheet/leverage reporting uncertainty
An unclear leverage profile creates persistent uncertainty about capital structure, risk tolerance and return potential. If deleveraging is real, future ROE and lending capacity may be constrained; if a reporting anomaly, it indicates governance or disclosure weaknesses investors must monitor.

Bain Capital Specialty Finance (BCSF) vs. SPDR S&P 500 ETF (SPY)

Bain Capital Specialty Finance Business Overview & Revenue Model

Company DescriptionBain Capital Specialty Finance, Inc. is business development company specializing in direct loans to middle-market companies. The fund seeks to invest in senior investments with a first or second lien on collateral, senior first lien, stretch senior, senior second lien, unitranche, mezzanine debt, junior securities, other junior investments, and secondary purchases of assets or portfolios that primarily consist of middle-market corporate debt. It typically invests in companies with EBITDA between $10 million and $150 million.
How the Company Makes MoneyBCSF generates revenue primarily through interest income on the loans and debt securities it holds in its investment portfolio. The company earns interest from its investments in first and second lien loans, which are typically higher-yielding compared to traditional fixed-income securities. Additionally, BCSF may generate revenue from management fees charged to its portfolio companies and from capital gains realized upon the sale of its equity investments. The company's revenue model is further supported by the growing demand for middle-market financing solutions, as well as strategic partnerships with financial institutions and industry experts that enhance its deal sourcing and investment capabilities.

Bain Capital Specialty Finance Earnings Call Summary

Earnings Call Date:Nov 10, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Feb 26, 2026
Earnings Call Sentiment Neutral
The earnings call highlighted a strong net investment income and stable credit quality, alongside an increase in deal activity and a resilient dividend strategy. However, challenges were noted in the decline of net asset value, lower total investment income, and net realized and unrealized losses. Despite these lowlights, the company's strong dividend yield and stable credit quality provide a positive outlook.
Q3-2025 Updates
Positive Updates
Strong Net Investment Income
Q3 net investment income per share was $0.45, representing an annualized yield on book value of 10.3% and exceeding the regular quarterly dividend by 7%.
Stable Credit Quality
Investments on non-accrual represented just 1.5% and 0.7% at amortized cost and fair value, respectively, as of September 30, with non-accruals relatively stable from the prior quarter.
Increased Deal Activity
New deal activity picked up across the middle market, driven by new LBO and M&A activity, with BCSS gross originations at $340 million for the quarter.
Resilient Dividend Strategy
Board declared a fourth quarter dividend equal to $0.42 per share and an additional dividend of $0.03 per share, maintaining a total dividend of $0.45 per share, or a 10.3% annualized rate.
High Dividend Yield
At BCSF's current market price, the dividend yield, inclusive of regular and special dividend for Q4, represents a 13% annualized yield.
Negative Updates
Net Asset Value Decline
Net asset value per share was $17.40, a decline of $0.16 per share from the prior quarter end, primarily due to a markdown on an idiosyncratic loan.
Lower Total Investment Income
Total investment income was $67.2 million for Q3, compared to $71 million for Q2, primarily driven by a decrease in other income from lower activity levels during the quarter.
Net Realized and Unrealized Losses
The company had net realized and unrealized losses of $10.5 million, primarily driven by one portfolio company investment.
Decrease in Portfolio Yield
The weighted average yield on the investment portfolio at amortized cost and fair value decreased to 11.1% and 11.2%, respectively, from 11.4% in the prior quarter.
Company Guidance
In the Bain Capital Specialty Finance earnings call for the third quarter ended September 30, 2025, several key financial metrics and guidance details were provided by the management team. The company reported a Q3 net investment income per share of $0.45, which translated to an annualized yield on book value of 10.3%, surpassing the regular quarterly dividend by 7%. Earnings per share for the quarter were $0.29, reflecting an annualized return on book value of 6.6%. The net asset value (NAV) per share declined by $0.16 from the previous quarter, settling at $17.40, primarily due to a markdown on one loan. The board declared a fourth-quarter dividend of $0.42 per share, along with an additional dividend of $0.03 per share, amounting to a total dividend for the quarter of $0.45 per share or a 10.3% annualized rate on ending book value. New investment fundings totaled $340 million during the quarter, with a weighted average spread of 550 basis points on new originations. The company maintained a disciplined approach to leverage, with a debt-to-equity ratio of 1.33 times, and emphasized its focus on the core middle market to drive attractive spreads on new investments. The management expressed confidence in maintaining the dividend despite potential headwinds from a lower interest rate environment and upcoming debt maturities, leveraging joint ventures and other growth levers to support earnings. The company ended the quarter with a strong liquidity position of $570 million.

Bain Capital Specialty Finance Financial Statement Overview

Summary
Fundamentals are generally healthy with strong profitability and consistently positive operating/free cash flow, but recent TTM revenue decline and softer cash-flow growth temper momentum. Balance-sheet confidence is reduced by an apparent TTM debt shift versus prior years.
Income Statement
67
Positive
Profitability is strong across the period, with high net income margins in the annual reports and solid earnings in TTM (Trailing-Twelve-Months). Revenue expanded materially from 2020 to 2024, but momentum has softened recently: TTM (Trailing-Twelve-Months) revenue is down versus the prior year and margins appear lower than the 2024 annual level. A few reported margin figures (e.g., unusually high/negative values in earlier years) look inconsistent, which reduces confidence in the margin trend even though earnings remain healthy.
Balance Sheet
58
Neutral
The balance sheet shows moderate leverage in most annual periods (debt running a bit above equity), paired with a steady return on equity around the high-single to low-double digits—supportive of ongoing profitability. However, TTM (Trailing-Twelve-Months) shows zero total debt versus meaningful debt in prior years, suggesting either a major deleveraging event or a data inconsistency; that uncertainty tempers the score. Overall asset levels are stable and equity has been steady to slightly rising, but leverage remains a key point to monitor based on the historical pattern.
Cash Flow
63
Positive
Cash generation is generally solid: operating cash flow and free cash flow are consistently positive, and free cash flow closely tracks net income across periods, indicating earnings quality is reasonably supported by cash. That said, free cash flow growth is negative in the most recent periods (TTM and 2024), implying some softening in cash generation. Also, operating cash flow coverage is volatile across years (including a negative reading in 2022), pointing to periodic swings in cash conversion.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue192.05M212.88M218.00M168.82M175.41M77.22M
Gross Profit110.18M138.19M137.99M116.51M124.06M13.91M
EBITDA97.34M123.89M126.73M106.32M119.94M8.51M
Net Income93.11M119.42M123.38M105.48M119.81M8.28M
Balance Sheet
Total Assets2.72B2.63B2.47B2.59B2.57B2.60B
Cash, Cash Equivalents and Short-Term Investments67.04M53.52M49.40M59.78M117.42M54.68M
Total Debt1.50B1.39B1.26B1.39B1.41B1.46B
Total Liabilities1.59B1.49B1.34B1.48B1.47B1.54B
Stockholders Equity1.13B1.14B1.14B1.12B1.10B1.07B
Cash Flow
Free Cash Flow87.80M112.58M125.87M114.21M54.49M75.94M
Operating Cash Flow87.80M112.58M125.87M114.21M54.49M75.94M
Investing Cash Flow-105.41M-139.68M93.40M-431.04M211.06M13.48M
Financing Cash Flow42.88M14.25M-231.43M238.33M-138.63M-76.52M

Bain Capital Specialty Finance Technical Analysis

Technical Analysis Sentiment
Negative
Last Price13.50
Price Trends
50DMA
13.66
Negative
100DMA
13.62
Negative
200DMA
13.94
Negative
Market Momentum
MACD
-0.02
Negative
RSI
50.15
Neutral
STOCH
68.10
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For BCSF, the sentiment is Negative. The current price of 13.5 is above the 20-day moving average (MA) of 13.34, below the 50-day MA of 13.66, and below the 200-day MA of 13.94, indicating a neutral trend. The MACD of -0.02 indicates Negative momentum. The RSI at 50.15 is Neutral, neither overbought nor oversold. The STOCH value of 68.10 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for BCSF.

Bain Capital Specialty Finance Risk Analysis

Bain Capital Specialty Finance disclosed 2 risk factors in its most recent earnings report. Bain Capital Specialty Finance reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Bain Capital Specialty Finance Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
70
Outperform
$816.68M9.079.07%10.80%-6.30%-6.92%
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
67
Neutral
$854.13M12.695.43%14.17%36.15%-38.59%
66
Neutral
$1.06B8.158.75%17.34%-16.58%65.24%
62
Neutral
$888.05M9.528.18%13.18%-26.08%-27.65%
60
Neutral
$851.29M24.613.44%13.64%36.91%-48.79%
60
Neutral
$859.53M10.257.03%13.63%-8.23%-35.72%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
BCSF
Bain Capital Specialty Finance
12.83
-3.64
-22.10%
NMFC
New Mountain Finance
8.09
-2.43
-23.10%
PFLT
Pennantpark $
8.18
-1.81
-18.09%
SLRC
SLR Investment Corp.
14.41
-1.43
-9.03%
GSBD
Goldman Sachs BDC
9.07
-2.39
-20.86%
CGBD
Carlyle Secured Lending Inc
11.10
-5.19
-31.86%

Bain Capital Specialty Finance Corporate Events

Business Operations and StrategyPrivate Placements and Financing
Bain Capital Specialty Finance Issues New Senior Unsecured Notes
Positive
Jan 29, 2026

On January 29, 2026, Bain Capital Specialty Finance, Inc. entered into a Fourth Supplemental Indenture with U.S. Bank Trust Company, National Association, covering the issuance of $350 million in 5.950% notes due March 1, 2031, which were sold in a registered offering that closed the same day. The notes, general unsecured obligations ranking senior to subordinated debt and pari passu with other unsecured unsubordinated obligations, carry semi-annual interest payments starting September 1, 2026, include change-of-control repurchase protections and Investment Company Act-related asset coverage covenants, and generated approximately $342.5 million in net proceeds that the company plans to use to repay outstanding secured indebtedness under its financing arrangements and for general corporate purposes, effectively extending its debt maturity profile and shifting its capital structure toward more unsecured funding.

The most recent analyst rating on (BCSF) stock is a Hold with a $15.00 price target. To see the full list of analyst forecasts on Bain Capital Specialty Finance stock, see the BCSF Stock Forecast page.

Private Placements and Financing
Bain Capital Specialty Finance Issues $350 Million 2031 Notes
Positive
Jan 23, 2026

On January 22, 2026, Bain Capital Specialty Finance, Inc. entered into an underwriting agreement with BCSF Advisors, LP and a syndicate of underwriters led by Wells Fargo Securities, J.P. Morgan Securities, and SMBC Nikko Securities America to issue and sell $350 million of 5.950% notes due 2031. The transaction, conducted under the company’s existing shelf registration, adds a sizable tranche of long-dated, fixed-rate debt to its capital structure, reinforcing its funding base and potentially supporting future lending activity, while customary indemnification and covenant provisions align with standard market practice and help manage legal and underwriting risks for all parties involved.

The most recent analyst rating on (BCSF) stock is a Buy with a $15.50 price target. To see the full list of analyst forecasts on Bain Capital Specialty Finance stock, see the BCSF Stock Forecast page.

Business Operations and StrategyDividendsFinancial Disclosures
Bain Capital Specialty Finance Declares Special Cash Dividend
Positive
Dec 22, 2025

On December 22, 2025, Bain Capital Specialty Finance, Inc. announced that its board had declared a special cash dividend of $0.15 per share, to be paid on January 26, 2026, to shareholders of record as of December 31, 2025. The company said the special distribution, driven by over-earnings during the year, is intended to help manage its tax and regulated investment company distribution requirements, while supporting disciplined capital management and maintaining spillover income to underpin the stability of its regular dividend and the gradual growth of net asset value per share over time.

The most recent analyst rating on (BCSF) stock is a Buy with a $16.00 price target. To see the full list of analyst forecasts on Bain Capital Specialty Finance stock, see the BCSF Stock Forecast page.

DividendsFinancial Disclosures
Bain Capital Specialty Finance Announces Q3 Results and Dividend
Positive
Nov 10, 2025

On November 10, 2025, Bain Capital Specialty Finance announced its financial results for the third quarter ending September 30, 2025, and declared a fourth quarter dividend of $0.42 per share, along with an additional $0.03 per share dividend previously announced. The company reported strong earnings driven by high net investment income, which exceeded their regular dividend, and maintained healthy credit performance. The announcement reflects Bain Capital Specialty Finance’s robust operational performance and strategic positioning in the middle-market lending space, potentially benefiting stakeholders with continued high-quality investment opportunities.

The most recent analyst rating on (BCSF) stock is a Buy with a $16.00 price target. To see the full list of analyst forecasts on Bain Capital Specialty Finance stock, see the BCSF Stock Forecast page.

Executive/Board Changes
Bain Capital Appoints New General Counsel Sabrina Rusnak-Carlson
Neutral
Nov 6, 2025

On November 5, 2025, Bain Capital Specialty Finance appointed Sabrina Rusnak-Carlson as General Counsel. Her extensive experience in credit and public equity law, along with her previous roles at First Eagle Alternative Credit and Proskauer Rose LLP, positions her to significantly contribute to the company’s legal and strategic operations.

The most recent analyst rating on (BCSF) stock is a Buy with a $16.00 price target. To see the full list of analyst forecasts on Bain Capital Specialty Finance stock, see the BCSF Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 30, 2026